Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
about
The renal nerves in chronic heart failure: efferent and afferent mechanismsThe sympathetic nervous system alterations in human hypertensionTemporal profile and mechanisms of the prompt sympathoexcitation following coronary ligation in Wistar ratsThe human sympathetic nervous system: its relevance in hypertension and heart failureSympathetic nervous system overactivity and its role in the development of cardiovascular diseaseChronic subcutaneous brain natriuretic peptide therapy in asymptomatic systolic heart failure.Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure.Morning surge of ventricular arrhythmias in a new arrhythmogenic canine model of chronic heart failure is associated with attenuation of time-of-day dependence of heart rate and autonomic adaptation, and reduced cardiac chaos.New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.Chronic electrical stimulation of the carotid sinus baroreflex improves left ventricular function and promotes reversal of ventricular remodeling in dogs with advanced heart failure.Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.Mechanisms and clinical consequences of untreated central sleep apnea in heart failurePrediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging.Neural control of circulation and exercise: a translational approach disclosing interactions between central command, arterial baroreflex, and muscle metaboreflex.Depletion of cardiac catecholamine stores impairs cardiac norepinephrine re-uptake by downregulation of the norepinephrine transporter.Potential autonomic nervous system effects of statins in heart failure.Atorvastatin and statins in the treatment of heart failure.Baroreflex activation for the treatment of heart failure.Cardiac I123-MIBG correlates better than ejection fraction with symptoms severity in systolic heart failure.Sympathetic mechanisms, organ damage, and antihypertensive treatment.Skeletal muscle vasodilatation during maximal exercise in health and disease.Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease.Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.Prognostic Value of the Change in Heart Rate From the Supine to the Upright Position in Patients With Chronic Heart FailureSympathetic activation in cardiovascular disease: evidence, clinical impact and therapeutic implications.Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials.Sympathetic Activation in Chronic Heart Failure: Potential Benefits of Interventional Therapies.Current and future developments in the field of central sleep apnoea.Central Angiotensin-II Increases Blood Pressure and Sympathetic Outflow via Rho Kinase Activation in Conscious Rabbits.The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Chronic adrenaline treatment fails to down-regulate the Del301-303-alpha2B-adrenoceptor in neuronal cells.Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: a microneurographic study.Hypothalamic corticotrophin-releasing factor and norepinephrine mediate sympathetic and cardiovascular responses to acute intracarotid injection of tumour necrosis factor-alpha in the rat.Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.The catecholamine-beta-adrenoreceptor-cAMP system and prediction of cardiovascular events in hypertension.
P2860
Q26795502-9069CEE6-8417-463B-B45C-FBA0AD00DF3BQ26863516-40EB7947-D9AC-4B9E-AD2B-1ACE1A37B9E4Q27320093-A04F544E-3BBA-4388-A1F0-51F98F2CD4ACQ28264609-8CF5E3AB-FF12-407D-9F0F-553150C1546CQ28279754-FD9F0B83-5E0F-4D8F-939F-ECF442500A63Q30359729-DBFF8824-9D1B-40CB-AA35-F584D54448F6Q31046062-5F4BC573-EFE0-4E4D-9B86-A0A7CE9AEC56Q33784327-7A67BF0C-74BC-46CA-8954-CBFC9B80AF4AQ34070908-6EF20CA2-A9F6-492B-875C-93612126F999Q34387086-B33A1EF3-C335-454D-82E2-C8CBA494D052Q34543021-E6B191B9-CC7B-4D1B-B1AF-9FD88EF6F723Q34625492-ABF90D9B-AA1E-43E4-B7DC-5DAC3BDC9664Q35074395-FEF8BD1E-DFCF-4C0A-9E31-C3CBD2CD1056Q35335969-7AB981DA-A0B0-4E4E-9190-E3128AA02A25Q36025668-CD64ECC1-F7E8-4775-8DD3-F2F56D733A0DQ36244466-1DD7A841-6472-419D-8C41-DC14A37CD4D9Q36304139-18B5B5C3-B3D7-4E57-A25F-53330A203860Q36736899-925734CF-E762-4BFF-A5B3-41B5E8EA788AQ37000767-8EFC41AB-A707-44BD-BB10-AC9F882E4F73Q37200514-5060ACA7-185E-4026-B94D-31B469078214Q37720773-28CF262F-684F-4103-BAFE-2C26720AA118Q37859637-7846ECC5-E537-4F13-8D52-189F03FB5091Q38048737-D15A7E59-7418-4079-98C2-B00F26B30B29Q38079913-9EA73847-4929-4039-917D-2069AB842791Q38088274-DBEF3495-3D79-4007-8E22-501A3E3F02CAQ38208753-3375F980-2F2C-44F4-8258-6254C4081F4DQ38266330-E8CCD128-BF6E-4A67-86EF-B054D35FBF66Q38389082-2CF9A5E5-A489-4ADB-8229-09D540EA428FQ38610953-59E026EC-CC8F-4A59-8980-2C6E30A52533Q38701402-2D92449A-7E52-4E13-8520-FEDBCF327061Q38837789-1D9798EF-EC77-42B2-9F33-ECC76F0671CAQ38846533-BE0A9F75-313F-4FF3-B87F-A02205B71E28Q39348251-73591FB8-6EEC-467A-B914-C19D964BD088Q39548660-AC014A88-31A1-40D8-BED3-61EE9C8AE566Q39806031-29DAFA4A-DFC2-40C5-A1E5-527372179A11Q40160690-52CD08DD-AC19-4E0C-81FB-593B6FB83168Q42667317-86D5CA42-0058-49B1-B41F-28660D38759EQ43072830-61BD624A-466D-43EB-9531-4EBDD986ADEAQ43235357-136A59BA-FFB5-4FC1-AA49-EDA8D149CBA7Q43850952-29CAE6B2-A429-4985-A526-AA2F6223407B
P2860
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Effect of cardiac sympathetic ...... h in congestive heart failure.
@en
Effect of cardiac sympathetic ...... h in congestive heart failure.
@nl
type
label
Effect of cardiac sympathetic ...... h in congestive heart failure.
@en
Effect of cardiac sympathetic ...... h in congestive heart failure.
@nl
prefLabel
Effect of cardiac sympathetic ...... h in congestive heart failure.
@en
Effect of cardiac sympathetic ...... h in congestive heart failure.
@nl
P2093
P356
P1476
Effect of cardiac sympathetic ...... th in congestive heart failure
@en
P2093
H P Brunner-La Rocca
P304
P356
10.1053/EUHJ.2000.2407
P577
2001-07-01T00:00:00Z